The tweet was deleted by the author.
But we saved everything 🙂.
Nuvation Bio expands Phase 3 SIGMA study in Europe: Can NUVB recover above the MA-20?
Nuvation Bio Inc. said its pivotal Phase 3 SIGMA trial of an investigational therapy for IDH1-mutant glioma will be expanded to six major European countries. The stock edges higher on the day, trading at $4.59.
Highlights
- Nuvation Bio is expanding its Phase 3 SIGMA study for IDH1-mutant glioma therapy to the UK, France, Sweden, Germany, Italy, and Spain.
- 44 of 48 analysts rate Nuvation Bio stock a buy, with a median price target of $12 and none at sell.
- Nuvation Bio stock edges higher on the day, trading at $4.59.
Nuvation Bio Inc. announced it is expanding its pivotal Phase 3 SIGMA study of its investigational therapy for IDH1-mutant glioma to six European countries: the UK, France, Sweden, Germany, Italy, and Spain. The update was shared through the company's own official channel. The company is focused on tackling challenges in cancer treatment and was founded by David Hung, M.D. in 2018, according to PR Newswire.
View post on X Loading...
Bearish structure holds as range stretches near oversold levels
The intraday range in the latest session widened well beyond the weekly average, between $4.43 and $4.6. Shares of Nuvation Bio remain locked below their MA-20, MA-50, and MA-200, sustaining a bearish daily structure. With the current RSI at 33.9 nearing oversold territory, the decline is beginning to look stretched, hinting at potential near-term stabilization. The nearest resistance sits at the MA-20 level of $4.79.
Odds firmly favor downside as traders eye $4.79 resistance
To gauge whether the event gains traction, traders should monitor a potential close above $4.79. Price action in the latest session expanded into a broad intraday span from $4.43 to $4.6. Even with a sustained move higher and a firm trend over the past week, the outlook for the coming trading week suggests less than 20% upside probability and more than 80% downside probability, with an expected trading range between $4.34 and $4.83. A move above $4.79 would indicate buyers are stepping in, while a fall below $4.36 would suggest the move is being faded. On the weekly chart, the longer-term picture stays negative.
Earlier, analysts noted that Nuvation Bio’s technical structure had remained broadly constructive despite a lack of near-term market catalysts. The current expansion of its pivotal trial into major European markets adds strategic scope, with traders now focused on any decisive move beyond $4.79 as a signal for trend reversal.
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Subscribe to TU news
Did you like the article?
Top News
Top 5 companies for you
United States
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
Live News
